Epzicom
Product Images NDC 53808-0767

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Epzicom (NDC 53808-0767). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Epzicom Tablets Label (Epzicom 600mg300mg (gsk))

Epzicom Tablets Label (Epzicom 600mg300mg (gsk))
Label for EPZICOM 600MG/300MG tablets, prescription only, provided in a quantity of 30 tablets. The label includes batch information and expiration date. The product is packaged by DOH Central Pharmacy, located in Tallahassee, FL.*
FDA Label Image

Abacavir Sulfate Structural Formula (D89c5e30 3a62 4f41 B1ff Edffcac143f7 01)

Abacavir Sulfate Structural Formula (D89c5e30 3a62 4f41 B1ff Edffcac143f7 01)
Chemical structure diagram showing the molecular structure associated with EPZICOM. The diagram includes detailed depictions of nitrogen and carbon ring systems, a cyclopropylamine group, and an attached side chain, along with a sulfate moiety indicated outside the brackets.*
FDA Label Image

Lamivudine Structural Formula (D89c5e30 3a62 4f41 B1ff Edffcac143f7 02)

Lamivudine Structural Formula (D89c5e30 3a62 4f41 B1ff Edffcac143f7 02)
Chemical structure of EPZICOM, showing a fused pyrimidine and thiazole ring system with an attached hydroxymethyl substituent.*
FDA Label Image

Figure 1: Hypersensitivity-related Symptoms Reported With ≥10% Frequency In Clinical Trials (n = 206 Patients) (D89c5e30 3a62 4f41 B1ff Edffcac143f7 03)

Figure 1: Hypersensitivity-related Symptoms Reported With ≥10% Frequency In Clinical Trials (n = 206 Patients) (D89c5e30 3a62 4f41 B1ff Edffcac143f7 03)
A vertical bar chart depicting the percentage occurrence of various symptoms including fever, rash, malaise, headache, myalgia, chills, diarrhea, lymphadenopathy, nausea/vomiting, abdominal pain, cough, candidiasis, thrombocytopenia, and peripheral neuropathy. The y-axis represents percentage values, and the x-axis lists symptoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.